Merck & Co Inc

NYSE: MRK
$96.31
-$2.05 (-2.1%)
Closing Price on November 15, 2024

MRK Articles

General Electric, JPMorgan, Merck, and Coca-Cola weighed on the Dow Thursday.
Merck & Co., Inc. (NYSE: MRK) shares took a small step back on Thursday after the company announced a key approval from the U.S. Food and Drug Administration. The agency has now approved Keytruda...
Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.
DowDuPont and GE were Tuesday's leading gainers among the Dow 30 stocks while Walmart and Merck, Monday's big gainers, were Tuesday's leading losers in a day of virtually no change to the index.
Walmart, Merck, Home Depot, and Visa were among nearly two dozen stocks that contributed to Friday's hike in the Dow's index increase.
It’s no surprise that it was only a matter of time before the usage and storage of big data and analytics would come to the health care sector, and many of the top companies are starting to apply...
Exxon, Chevron, Merck, and JPMorgan posted solid gains Wednesday to lead the Dow higher.
The May 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Boeing and Merck held the Dow up Wednesday while General Electric and Disney provide the downdraft.
This year marks the 54th annual meeting of the American Society of Clinical Oncology, the world’s largest clinical cancer conference.
The U.S. Food and Drug Administration on Thursday published a list of brand-name drug companies that the agency has received complaints against for obstructing development of generic versions of...
Cisco, Walmart, Merck, and Johnson & Johnson were among the leading losers on the Dow Thursday.
The Dow is set to close with a modest gain Friday led by Verizon, Merck, UnitedHealth, and Johnson & Johnson.
The April 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
DowDuPont, General Electric, Exxon Mobil, and Merck led the Dow to a solid gain Wednesday.